Pulmonx Corporation Book Value 2011-2026 | LUNG

Book value is a financial metric that reflects the value of a company's assets minus its liabilities as of a specific date, according to accounting records. In simple terms, it is the amount that would remain for the owners of the company if all assets were sold and all debts paid off.

What is included in book value

Assets — all company resources: real estate, equipment, inventory, cash, accounts receivable, and others.
Liabilities — all debts and financial obligations: loans, accounts payable, taxes, and other obligations.

Features of the metric

Assessment of the company's "real" value
Book value shows how much the company is worth according to accounting data, that is, the value of its property taking debts into account.
Comparison with market capitalization
Comparing book value and the market price of shares helps to understand whether the company is overvalued or undervalued by the market.
Indicator of financial stability
If the book value is high, it indicates the company has significant assets, which reduces risks for investors.
Key component for financial ratios
Many metrics, such as the price-to-book ratio (P/B), use book value to analyze the attractiveness of shares.

Annual Book Value Pulmonx Corporation

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
54.1 M	85.8 M	118 M	154 M	193 M	226 M	-187 M	-167 M	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
226 M	-187 M	59.6 M

Quarterly Book Value Pulmonx Corporation

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
60 M	69.1 M	77.7 M	85.8 M	93.9 M	101 M	110 M	118 M	126 M	134 M	144 M	154 M	163 M	172 M	182 M	193 M	203 M	209 M	216 M	226 M	226 M	226 M	226 M	18 M	18 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
226 M	18 M	142 M

Book Value of other stocks in the Medical devices industry

Issuer	Book Value	Price	% 24h	Market Cap	Country
Align Technology ALGN	3.85 B	$ 186.15	3.03 %	$ 13.9 B	USA
Alphatec Holdings ATEC	791 M	$ 11.57	2.84 %	$ 1.74 B	USA
Avinger AVGR	-6.2 M	-	-20.74 %	$ 369 K	USA
Axonics Modulation Technologies AXNX	570 M	-	-	$ 3.31 B	USA
Aziyo Biologics AZYO	27.7 M	-	1.37 %	$ 20.5 M	USA
AxoGen AXGN	129 M	$ 34.98	4.51 %	$ 1.61 B	USA
BioSig Technologies BSGM	133 M	-	37.08 %	$ 85.7 M	USA
Conformis CFMS	54.2 M	-	-	$ 16.4 M	USA
GenMark Diagnostics, Inc. GNMK	196 M	-	-	$ 1.77 B	USA
Acutus Medical AFIB	-879 K	-	-26.83 %	$ 2.62 M	USA
EDAP TMS S.A. EDAP	40.9 M	$ 3.33	0.15 %	$ 125 M	France
AdaptHealth Corp. AHCO	1.53 B	$ 12.54	1.78 %	$ 1.69 B	USA
Allied Healthcare Products AHPI	19.7 M	-	3.58 %	$ 2.21 M	USA
Lianluo Smart Limited LLIT	272 M	-	24.59 %	$ 44.8 M	China
Obalon Therapeutics, Inc. OBLN	25.5 M	-	-5.86 %	$ 30.6 M	USA
Bio-Rad Laboratories BIO	6.57 B	$ 292.47	1.49 %	$ 8.25 B	USA
Cytosorbents Corporation CTSO	5.9 M	$ 0.57	-2.41 %	$ 35.5 M	USA
Inogen INGN	192 M	$ 6.45	-	$ 172 M	USA
IRIDEX Corporation IRIX	4.92 M	$ 1.03	-	$ 17.4 M	USA
Bruker Corporation BRKR	1.82 B	$ 40.21	2.97 %	$ 5.99 K	USA
Boston Scientific Corporation BSX	43.7 B	$ 64.38	1.9 %	$ 95.3 B	USA
Apollo Endosurgery APEN	32.6 M	-	-	$ 475 M	USA
Cardiovascular Systems CSII	249 M	-	0.15 %	$ 844 M	USA
LENSAR LNSR	-12.2 M	$ 5.98	1.01 %	$ 71.5 M	USA
ClearPoint Neuro CLPT	28 M	$ 10.28	2.7 %	$ 291 M	USA
Dynatronics Corporation DYNT	3.26 M	-	14.99 %	$ 929 K	USA
Second Sight Medical Products EYES	15.7 M	-	-0.97 %	$ 54.4 M	USA
Electromed ELMD	43.2 M	$ 25.14	0.76 %	$ 213 M	USA
Myomo MYO	11.4 M	$ 0.75	3.23 %	$ 31.4 M	USA
CryoLife, Inc. CRY	58.1 M	-	-4.14 %	$ 702 M	USA
CHF Solutions, Inc. CHFS	6.23 M	-	1.15 %	$ 34.5 M	USA
Soliton, Inc. SOLY	243 M	-	-1.42 %	$ 435 M	USA
Hancock Jaffe Laboratories, Inc. HJLI	2.61 B	-	-1.98 %	$ 98.3 M	USA
Sintx Technologies SINT	2.93 M	$ 2.95	0.4 %	$ 8.18 M	USA
GBS GBS	2.81 M	-	-0.57 %	$ 7.12 M	USA
Itamar Medical Ltd. ITMR	229 M	-	0.03 %	$ 1.58 B	Israel
Misonix, Inc. MSON	30.4 M	-	-	$ 462 M	USA
Neovasc NVCN	52.2 M	-	-	$ 111 M	Canada
Globus Medical GMED	4.57 B	$ 95.0	2.17 %	$ 12.8 B	USA
Stryker Corporation SYK	22.4 B	$ 351.25	1.15 %	$ 134 B	USA
Tactile Systems Technology TCMD	219 M	$ 24.87	2.6 %	$ 569 M	USA
Helius Medical Technologies HSDT	2.35 M	$ 2.03	-	$ 1.23 M	USA
Butterfly Network BFLY	169 M	$ 4.39	2.45 %	$ 929 M	USA
Intersect ENT, Inc. XENT	550 M	-	-	$ 955 M	USA
TransMedics Group TMDX	473 M	$ 116.53	2.8 %	$ 3.96 B	USA
Tandem Diabetes Care TNDM	155 M	$ 20.62	2.59 %	$ 1.4 B	USA
BIOLASE BIOL	1.96 M	-	-13.19 %	$ 166 K	USA
OrthoPediatrics Corp. KIDS	347 M	$ 17.45	2.95 %	$ 409 M	USA
Delcath Systems DCTH	111 M	$ 10.71	2.49 %	$ 384 M	USA
Inspire Medical Systems INSP	781 M	$ 55.0	0.15 %	$ 1.62 B	USA